NCT02022709View on ClinicalTrials.gov

Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

November 18, 2017

Study Completion Date

March 13, 2018

Conditions
Obsessive-Compulsive DisorderAnxiety DisordersMental Disorders
Interventions
DRUG

Fluoxetine

The dosage depends on clinician's judgement ,but not over the maximum tolerated dosage.

DRUG

Sertraline

The dosage depends on clinician's judgement ,but not over the maximum tolerated dosage.

DRUG

Paroxetine

The dosage depends on clinician's judgement ,but not over the maximum tolerated dosage.

DRUG

Citalopram

The dosage depends on clinician's judgement ,but not over the maximum tolerated dosage.

DRUG

Fluvoxamine

The dosage depends on clinician's judgement ,but not over the maximum tolerated dosage.

BEHAVIORAL

Exposure and Response Prevention

8 exposure and response prevention (ERP) sessions,once a week

Trial Locations (1)

200030

Shanghai Mental Health Center, Shanghai

All Listed Sponsors
collaborator

Shanghai Municipal Science and Technology Commission

OTHER_GOV

collaborator

Shanghai Jiao Tong University School of Medicine

OTHER

lead

Shanghai Mental Health Center

OTHER

NCT02022709 - Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients | Biotech Hunter | Biotech Hunter